| Year |
Citation |
Score |
| 2023 |
Jezernik G, Gorenjak M, Potočnik U. MIF Variant rs755622 Is Associated with Severe Crohn's Disease and Better Response to Anti-TNF Adalimumab Therapy. Genes. 14. PMID 36833379 DOI: 10.3390/genes14020452 |
0.325 |
|
| 2022 |
Gorenjak M, Jezernik G, Krušič M, Skok P, Potočnik U. Identification of Novel Loci Involved in Adalimumab Response in Crohn's Disease Patients Using Integration of Genome Profiling and Isoform-Level Immune-Cell Deconvoluted Transcriptome Profiling of Colon Tissue. Pharmaceutics. 14. PMID 36145641 DOI: 10.3390/pharmaceutics14091893 |
0.613 |
|
| 2021 |
Gorenjak M, Zupin M, Jezernik G, Skok P, Potočnik U. Omics data integration identifies ELOVL7 and MMD gene regions as novel loci for adalimumab response in patients with Crohn's disease. Scientific Reports. 11: 5449. PMID 33750834 DOI: 10.1038/s41598-021-84909-z |
0.593 |
|
| 2020 |
Hernandez-Pacheco N, Gorenjak M, Jurgec S, Corrales A, Jorgensen A, Karimi L, Vijverberg SJ, Berce V, Schieck M, Acosta-Herrera M, Kerick M, Samedy-Bates LA, Tavendale R, Villar J, Mukhopadhyay S, et al. Combined analysis of transcriptomic and genetic data for the identification of loci involved in glucocorticosteroid response in asthma. Allergy. PMID 32786158 DOI: 10.1111/All.14552 |
0.313 |
|
| 2019 |
Gorenjak M, Repnik K, Jezernik G, Jurgec S, Skok P, Potočnik U. Genetic prediction profile for adalimumab response in Slovenian Crohn's disease patients. Zeitschrift Fur Gastroenterologie. 57: 1218-1225. PMID 31610585 DOI: 10.1055/A-0981-6516 |
0.595 |
|
| 2019 |
Hernandez-Pacheco N, Vijverberg SJ, Gorenjak M, Flores C, Francis B, Farzan N, Corrales A, Karimi L, Maroteau C, Schieck M, Repnik K, Pérez-Méndez L, Soares P, Berce V, Tavendale R, et al. Meta-analysis of inhaled corticosteroids response in children with asthma European Respiratory Journal. 54. DOI: 10.1183/13993003.Congress-2019.Pa5434 |
0.316 |
|
| 2018 |
Primec M, Klemenak M, Di Gioia D, Aloisio I, Bozzi Cionci N, Quagliariello A, Gorenjak M, Mičetić-Turk D, Langerholc T. Clinical intervention using Bifidobacterium strains in celiac disease children reveals novel microbial modulators of TNF-α and short-chain fatty acids. Clinical Nutrition (Edinburgh, Scotland). PMID 29960810 DOI: 10.1016/J.Clnu.2018.06.931 |
0.325 |
|
| 2017 |
Pernat Drobež C, Repnik K, Gorenjak M, Ferkolj I, Weersma RK, Potočnik U. DNA polymorphisms predict time to progression from uncomplicated to complicated Crohn's disease. European Journal of Gastroenterology & Hepatology. PMID 29293112 DOI: 10.1097/Meg.0000000000001055 |
0.338 |
|
| 2016 |
Primec M, Klemenak M, Aloisio I, Gorenjak M, Gioia DD, Mičetić-Turk D, Langerholc T. Faecal Concentrations of Short-chain Fatty Acids and Selected Bacteria in Healthy and Celiac Children International Journal of Celiac Disease. 4: 95-101. DOI: 10.12691/Ijcd-4-3-6 |
0.308 |
|
| 2015 |
Repnik K, Gorenjak M, Potočnik U. Association of 10 p Locus with Slovenian Inflammatory Bowel Disease Patients Annual Research & Review in Biology. 8: 1-9. DOI: 10.9734/Arrb/2015/20566 |
0.364 |
|
| 2014 |
Gorenjak M, Gradišnik L, Trapečar M, Pistello M, Kozmus CP, Škorjanc D, Skok P, Langerholc T, Cencič A. Improvement of lipid profile by probiotic/protective cultures: study in a non-carcinogenic small intestinal cell model. The New Microbiologica. 37: 51-64. PMID 24531171 |
0.559 |
|
| 2012 |
Gorenjak M, Skok P, Cencic A. Novel promising functional cell models to study molecular events in metabolic syndrome Nutritional Therapy and Metabolism. 30: 34-41. |
0.538 |
|
| Show low-probability matches. |